Vertebrate Hox genes act as developmental architects by patterning embryonic structures like axial skeletal elements, limbs, brainstem territories, or neural crest derivatives. While active during the patterning steps of development, these genes turn out to be downregulated in specific differentiation programs like that leading to chondrogenesis. To investigate why chondrocyte differentiation is correlated to the silencing of a Hox gene, we generated transgenic mice allowing Cremediated conditional misexpression of Hoxa2 and induced this gene in Collagen 2 alpha 1-expressing cells committed to enter chondrogenesis. Persistent Hoxa2 expression in chondrogenic cells resulted in overall chondrodysplasia with delayed cartilage hypertrophy, mineralization, and ossification but without proliferation defects. The absence of skeletal patterning anomaly and the regular migration of precursor cells indicated that the condensation step of chondrogenesis was normal. In contrast, closer examination at the differentiation step showed severely impaired chondrocyte differentiation. In addition, this inhibition affected structures independently of their embryonic origin. In conclusion, for the first time here, by a cell-type specific misexpression, we precisely uncoupled the patterning function of Hoxa2 from its involvement in regulating differentiation programs per se and demonstrate that Hoxa2 displays an anti-chondrogenic activity that is distinct from its patterning function.
Introduction
The vertebrate skeleton is a composite organ constituted of limited membranous structures arising by direct differentiation of mesenchyme into bone and a majority of endochondral elements formed from a preliminary cartilaginous anlage. According to the precursor tissue, one can distinguish the appendicular skeleton, which derives from lateral mesoderm, the axial skeleton, originating from paraxial mesoderm, and the cephalic skeleton, essentially derived from the neural crest (NC) cells (Couly et al., 1993; Lengele´et al., 1996; Christ et al., 2000; Santagati and Rijli, 2003) . These precursors are of distinct embryonic origin as paraxial and lateral mesoderm both arise from a primitive mesodermal layer, whereas NC cells spread out from neural ectoderm to give the so-called ectomesenchyme.
After mesenchymal transformation of the sclerotome, budding of limb mesenchyme, or sprouting of skeletogenic NC cells, chondrogenic condensation occurs. This process is initiated by the migration and aggregation of precursor cells under the influence of fibroblast growth factors (FGFs) and bone morphogenic proteins (BMPs). The precise shape and location of condensations are mostly defined by the expression pattern of homeotic (Hox) genes (Christ et al., 2000) . Condensation also requires Pax1 and Pax9 gene products that allow precursor cells to respond to inductive signals such as Sonic Hedgehog (Shh) and prevent them from either apoptosis or premature differentiation (Peters et al., 1999) . Recently, Pax1 and -9 have been shown to be required for the activation of Nkx-3.2 (Bapx1), a Shh-induced factor, which in turn activates the chondrogenic marker Sox9 (Zeng et al., 2002; Rodrigo et al., 2003) . The critical activation of Sox9 then marks the onset of chondrogenic differentiation. Indeed, if Sox9 is inactivated after the condensation step, cartilage fails to develop (Akiyama et al., 2002) .
Once at the right place, condensations grow and cells differentiate to become proliferating chondrocytes. While the proliferation of precursor cells is notably controlled by factors of the retinoblastoma (Rb) family, namely p107 and p130 (Rossi et al., 2002) , chondrocytic differentiation still depends upon FGF (Murakami et al., 2000) , BMP (Wan et al., 2001) , as well as on ephrins (Stadler et al., 2001 ) and many other factors (Hoffmann et al., 2002; Scheijen et al., 2003) . Further to their proliferation, chondrocytes become hypertrophic, cartilage undergoes mineralization, is resorbed, and replaced by bone. Here again, Sox9, but also the Wnt, Indian Hedgehog, and parathyroid hormone signaling cascades, coordinate these maturation steps (Yang et al., 2003) .
Hox homeotic genes are well-known patterning genes that confer identity to skeletogenic condensations (Krumlauf, 1994) . These genes are globally expressed in condensing cells but are turned off as differentiation starts. Hoxa2, the most anteriorly expressed Hox gene, contributes to the specification of the second branchial arch (BA2). Indeed, Hoxa2 inactivation results in the homeotic transformation of BA2, which therefore gives rise to the mirror duplication of BA1 structures (Gendron-Maguire et al., 1993; Rijli et al., 1993) . Conversely, ectopic expression of Hoxa2 in the first BA of fish, frog, and chick leads to the reverse transformation (Grammatopoulos et al., 2000; Pasqualetti et al., 2000; Hunter and Prince, 2002) . The homeotic transformation of BA2 in Hoxa2 knock-out (KO) mice is paralleled by the activation of the BA1-specific markers Ptx1 and Lhx6. In addition, the phenotype of the Hoxa2 KO is partially rescued in Hoxa2/Ptx1 double KO. It was thus proposed that Hoxa2 confers the BA2 fate by restricting Ptx1 and Lhx6 expression domains anteriorly to BA2 in wild-type (WT) embryos. As Ptx1 and Lhx6 activation in BA1 is under the control of FGFs, Hoxa2 activity was suggested to interfere at some point with the FGF signaling cascade (Bobola et al., 2003) .
While previous studies on Hoxa2 function basically addressed its roles in the patterning of embryonic structures, the link between Hoxa2 activity and differentiation programs per se remains elusive. In particular, the reason why, once properly located and specified, cartilage precursors turn their Hox genes off remains unclear. Interestingly, Sox9 and Cbfa1 expression domains have been reported to be extended in Hoxa2 KO mice (Kanzler et al., 1998) . As these genes are well-known chondro-and osteogenic lineage markers, this phenomenon was first interpreted as the loss of a putative Hoxa2 anti-skeletogenic activity in the BA2 area. However, in both the Hoxa2 KO and Hoxa2 ectopic expression experiments (Grammatopoulos et al., 2000; Pasqualetti et al., 2000) , it was not possible to discriminate whether the phenotypic alterations were imputable to the involvement of Hoxa2 in the patterning of developing structures or to its possible effect on differentiation programs of cartilage and bone per se.
To investigate specifically why Hoxa2 needs to be switched off by the onset of chondrocyte differentiation, we analyzed the impact of a sustained Hoxa2 activity on cartilage development. In that respect, we generated transgenic mouse lines allowing Cre-mediated Hoxa2 induction and we crossed these lines with mice bearing a Cre recombinase gene under the control of the cartilagespecific Col2a1 promoter (Ovchinnikov et al., 2000) . Thereby, we caused Hoxa2 expression to persist beyond the onset of chondrocyte differentiation, i.e., beyond that precise stage it should be turned off, and to extend to larger territories than its normal sphere of action. Induced mice display delayed cartilage development and severe chondrodysplasia. Histological characterization of developing cartilaginous elements in these mice further demonstrates that Hoxa2 activity impairs chondrogenesis from its earliest steps. As this downregulatory effect is exerted after the condensation step, we propose that it is independent of the patterning function of Hoxa2 but rather results from the interference with a common basic chondrogenic program.
Methods

Plasmid constructs
The transgene for the conditional expression of Hoxa2 was obtained as follows: a Hoxa2 genomic fragment spanning 47 bp of the 5 0 untranslated region (UTR) plus the entire coding sequence was inserted downstream of a 4.3 kbp EcoRI-AluI fragment of the human b-actin promoter including the first intron (IVS1) of the gene (Leavitt et al., 1984; Fig. 1A) . This fragment was cloned upstream of a 4.4 kbp reporter cassette. The reporter cassette contains a 1.1 kbp internal ribosome entry site (IRES) from Theiler's virus (Shaw-Jackson and Michiels, 1999) fused to a nuclear localizing sequence (NLS)-tagged Escherichia coli lacZ gene and followed by the SV40 late region polyadenylation signal. A loxP-flanked cassette to arrest transcription (STOP) was inserted between the b-actin promoter and Hoxa2 sequence. The stopping cassette was obtained from pBS302 (Invitrogen, Carlsbad, CA) after addition of a neomycin resistance gene (Kellendonk et al., 1996) to a unique BglII site. Introduction of the stopping cassette into the transgene was performed in vitro, using the Crerecombinase system (Clontech, Mountain View, CA; construct details available upon request).
Generating and maintenance of transgenic mice
SpeI and/or SfiI linearized transgenes were microinjected into the male pronucleus of inbred FVB zygotes and transferred into C57Bl/ 6 Â C3h F1 foster mice at E0.5. Transgenics were identified by polymerase chain reaction (PCR) screening using specific primers for ''fragment 2'' (Figs. 1A,1B ). Transgenics were mated with mice for a collagen IIa1 promoter-directed Cre-expression (Col2a1-Cre; Ovchinnikov et al., 2000) . Col2a1-Cre and Col2a1/Hoxa2-lacZ simple and double transgenics were mated with R26R mice (Soriano, 1999) for Cre-activity detection. Excision of the STOP cassette was assayed with PCR primers for ''fragment 1'' (Figs. 1A,1B ).
Western blotting
To evaluate the level of Hoxa2 expression upon Cre-mediated induction, E13.5 embryos were collected and individually processed for whole protein extraction. Thirty micrograms of each protein extract, as estimated by the Pierce bicinchoninic acid protein assay kit (Pierce Biotechnology Inc., Rockford, IL), were run on sodium dodecyl sulfate-polyacryilamide gel electrophoresis and transferred to a nitrocellulose membrane. Immuno-detection of Hoxa2 was performed with the goat polyclonal anti-Hoxa2 antibody (N-20, sc17149; Santa Cruz Biotechnology Inc., Santa Cruz, CA) at a 1:20,000 dilution, followed by a secondary reaction with the peroxidase-coupled anti-goat immunoglobulin (IgG; PI-9500; Vector Laboratories, Burlingame, CA) used at 1:200. Detection of b-actin involved the rabbit anti-actin (20-33) antibody (A5060; Sigma, Bornem, Belgium) at 1:8,000 and the biotinylated antirabbit IgG (BA-1000; Vector) at 1:200 as a secondary antibody. Western blots were revealed by chemo-luminescent reactions (Pierce Supersignal West Pico trial kit) and scanned for quantification of detected proteins (EPSON Perfection 4990 Photo; data treatment with Image J v1.345 software). A semi-quantitative estimate of the level of Hoxa2 expression was obtained by comparison with the level of b-actin expression.
Whole-mount staining
For bone and cartilage staining, after removal of the skin and internal organs, embryos were fixed overnight in 95% ethanol, stained with 0.02% alcian blue in 4:1 95% ethanol:acetic acid for 2 days, washed in 95% ethanol, immersed in 2% KOH for 18 hr, stained in 75 mg/ml alizarin red in 1% KOH overnight, processed through a graded series of glycerol in ethanol and stored in 100% glycerol.
For cartilage staining, E13.5 embryos were fixed overnight in Bouin's solution, rinsed briefly with water, immersed for at least 1 hr in four changes of 1% ammonia in 70% ethanol, and stained with 0.05% alcian blue in 5% acetic acid. Embryos were rinsed three times in 5% acetic acid for 1-2 hr each and then once overnight. Specimens were dehydrated through graded ethanols, cleared, and stored in 2:1 benzyl alcohol:benzyl benzoate (BA:BB; Sigma).
For b-galactosidase activity detection (X-Gal staining), embryos harvested from E9.5 to 15.5 were fixed up to 60 min in 4% paraformaldehyde (PFA) and washed in 0.01% sodium deoxycholate, 0.02% NP-40 in phosphate-buffered saline (PBS; pH 7.4). Specimens were then stained overnight at room temperature in washing buffer containing 1 mg/ml X-gal (Sigma), 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and 2 mM MgCl 2 . Samples were subsequently rinsed, post-fixed in 4% PFA for 15 hr, dehydrated, and eventually processed through histology or cleared in BA:BB.
Histology and immunohistochemistry
Most embryos were fixed overnight in 4% PFA in PBS before embedding in paraffin. They were cut into 5-mm-thick sections that were stained with hematoxylin, alcian blue-nuclear fast red, or according to Von Kossa's procedure.
Immunohistochemical detection of type-X collagen, proliferating cell nuclear antigen (PCNA), Hoxa2, Fgfr3, and Sox9 was performed with rabbit anti-collagen X (Calbiochem), anti-PCNA (Santa Cruz), anti-Hoxa2 (kindly provided by A. Nazarali), antiFgfr3 (Santa Cruz), and anti-Sox9 (Sigma) as primary antibodies, respectively. Immunoperoxidase staining was carried out using the Envision1 kit (Dako, Glostrup, Denmark). Endogenous peroxidase was blocked with 0.03% hydrogen peroxide for 5 min. After three washes in distilled water, type-X collagen antigen was unmasked by 3-min microwave treatment in citrate buffer (10 mM, pH 6.0) and hyaluronidase from bovine testes (2 mg/ml in PBS, pH 7.0, Sigma) at room temperature. Unmasking of PCNA was performed by 10 min microwave treatment. Thereafter, the nonspecific antigenic sites were neutralized by 10% normal goat serum (NGS) in PBS for 30 min. The sections were then incubated overnight at 41C with the primary antibody (anti-collagen X, 1:400; anti-PCNA, 1:200; anti-Hoxa2, 1:800; anti-Fgfr3, 1:500; and antiSox9, 5 mg/ml). Then, they were washed twice in PBS and incubated with secondary goat anti-rabbit antibody conjugated with a peroxidase-labeled polymer. After three changes in PBS, peroxidase was revealed by the diaminobenzidine reaction. The sections were counterstained with hemalun or alcian blue-nuclear fast red, dehydrated, and finally mounted. Control experiments included omission of the first antibody. PCNA-positive cells were counted in microscopic fields delimited by two successive intervertebral disks.
Bone mineral density (BMD) determination
Under anesthesia (Drobac et al., 2004) , six Col2a1/Hoxa2-lacZ and six bS-Hoxa2-lacZ mice were scanned with a peripheral quantitative computed tomography (pQCT) XCT Research SA1 (Stratec Medizintechnik GmbH, Pforzhein, Germany) 1 day after birth. The Col2a1/Hoxa2-lacZ mice were scanned a second time after death, the bS-Hoxa2-lacZ mice after sacrifice at the equivalent time. Three 500-mm-thick midsagittal and paramedian sagittal slices spaced out of 250 mm were selected from a scout view image. The total scan lasted about 15 min. The voxel size was 70 mm. Images were analyzed with the XCT540 software provided with the pQCT. A 0.044 mm 2 region of interest (ROI) was selected in the third cervical (C3), sixth thoracic (C6), and fourth lumbal (L4) vertebrae on the best slice of each mouse. BMD ( mg HAP/cm 3 ) was measured for each ROI. The heights of three contiguous vertebrae of the cervical (C2, C3, C4), thoracic (T5, T6, T7), and lumbal (L3, L4, L5) regions were also measured with the software.
Results
Sustained Hoxa2 expression from the onset of chondrocyte differentiation results in a severe chondrodysplasia To investigate why Hoxa2 needs to be silenced once chondrocyte differentiation goes on, a binary Cre-loxP recombination system was used to generate conditional Hoxa2 expression in developing cartilage. We produced a construct that consists in the Hoxa2 genomic sequence placed under the control of the human b-actin promoter and translationally coupled to a lacZ reporter by an IRES. This construct was further modified by inserting a ''floxed'' cassette blocking transcription between the b-actin promoter and the Hoxa2 coding sequence, to give rise to a silent hb-actin-STOP-Hoxa2-IRES-lacZ transgene (bS-Hoxa2-lacZ for simplification, Fig. 1A ). Cell transfection assays, followed by b-galactosidase activity detection demonstrated that the construct was correctly expressed in the absence of the blocking cassette. In addition, transgene expression upon cotransfection experiments resulted in specific transactivation of known target reporters, providing evidence that an active Hoxa2 protein was expressed from the construct (data not shown).
The resulting bS-Hoxa2-lacZ transgene was microinjected into mouse zygotes and transgenic progeny was identified by PCR. Among eight transgenic founders, two were retained and mated with a heterozygous Col2a1-Cre strain that drives Cre-expression in differentiating chondrocytes (Ovchinnikov et al., 2000) . As strikingly similar skeletal phenotypes were observed in the progenies of both founders, the derived lines will be indistinctly discussed hereafter. In these bS-Hoxa2-lacZ transgenic lines, Cre-mediated excision of the blocking cassette was confirmed by PCR (Fig. 1B) . To ensure that the Hoxa2 protein was expressed upon inductive crossings, E13.5 embryos were collected and processed for whole-protein extraction and Western blotting. Extracts obtained from embryos bearing both the bSHoxa2-lacZ and Col2a1-Cre transgenes gave rise to a Hoxa2-specific signal (Fig. 1C) . In contrast, Hoxa2 expression was not detected in extracts obtained from WT or simple transgenic embryos. A semi-quantitative estimate of the Hoxa2 protein revealed that the relative expression of Hoxa2 varied by less than a factor two among double transgenic individuals (data not shown).
Upon mating with Col2a1-Cre mice, about one-fourth of the resulting double transgenics (Col2a1/Hoxa2-lacZ for simplification) died within the first few hours of life (17.5% of double transgenics at birth versus 25% at E18.5; Table 1 ). They presented a crumpled skin with a kinked tail, a shortened snout, and frequent palatal clefts (Fig. 1D) . Another quarter of the double transgenic littermates showed important growth retardation ( Fig. 1E ) and died within a few weeks. Finally, less than two-thirds of the double transgenics were viable, although mildly dwarf or malformed (15.5% of double transgenics at 12 weeks post partum, Table 1 ).
X-gal staining of E13.5 double transgenics confirmed specific transgene activation into a large set of developing cartilages (Figs. 2A,2B ). E. Coli b-galactosidase activity was detected all along the axial skeleton, from the proximal Meckel's cartilage and otic capsule to the tail tip. Rib processes and limbs were also clearly stained with an intense signal in limb joints. The strongest signal was detected in the cervico-occipital and proximal Meckel's cartilage regions. Unexpectedly, Cre-recombinase also appeared to induce the bSHoxa2-lacZ transgene into the whole body dermis from E15 onwards (data not shown), which could account for skin abnormalities in double-mutant newborns.
Skeletons of E18 fetuses (nine double Col2a1/Hoxa2-lacZ, five WT and five bS-Hoxa2-lacZ transgenics) and neonates (11 double Col2a1/Hoxa2-lacZ, five WT and five bS-Hoxa2-lacZ transgenics) were analyzed by differential staining of bones and cartilages. A global hypoplasia of both axial and appendicular elements was observed in all Col2a1/Hoxa2-lacZ mutants, while simple bS-Hoxa2-lacZ transgenics were indistinguishable from WT littermates (Figs. 3A,3G ). Col2a1/ Hoxa2-lacZ double transgenics displayed an overall less intense cartilage staining and a reduced axial length. The vertebral column curvature was flattened with cervical lordosis (arrowhead) and Spina bifida (arrow). The number of vertebrae and ribs was normal (Figs.  3B,3H ), but ossification of the vertebral bodies appeared delayed, particularly in the cervical spine (arrowhead). The limbs were never malformed but slightly reduced in size and the ossification of the autopod was always delayed (Figs. 3C,3I ). The skull presented either a reduced size or a brachycephaly (Figs. 3D,3J ). With regard to paraxial mesoderm derivatives, the supraoccipital was rarely formed. The neural arches, vertebral bodies, basisphenoid, basioccipital, and exoccipital were always severely reduced (Table 2; Figs. 3D,3J). Interestingly, the malformed vertebral bodies were often fused to the neural arches (Figs. 3B,3H) , and, in a similar way, the basioccipital was frequently joined to the exoccipitals (Figs. 3D,3J ). Concerning the NC derivatives, the basihyoid, otic capsule (of dual origin), and middle-ear ossicles were reduced or poorly ossified but never malformed (Figs.  3E,3K ). Meckel's cartilage was reduced, absent (Figs. 3E,3K), or sometimes split in its proximal part. The nasal capsule, pterygoid, tympanic, and presphenoid bones were also clearly reduced. In some cases, the palatine bones were so dramatically reduced that the presphenoid was apparent (Table 2 and Figs. 3F,3L) . The laryngeal and tracheal cartilages, the sternum, xiphoid process, and clavicles were normal, although slightly smaller. Most membranous bones of the face were also reduced so that actually all the examined skeletal structures appeared affected.
Col2a1-expressing chondrogenic precursors are normally abundant and distributed
No homeosis was expected to be observed in Col2a1/ Hoxa2-lacZ transgenics as only the differentiation step was targeted. Consistently, although clearly hypoplastic or locally interrupted, the proximal Meckel's cartilage and middle-ear ossicles appeared normally shaped in these pups. To further exclude any major patterning defect as a possible cause of the observed Col2a1/ Hoxa2-lacZ mutant phenotype, we verified that chondrogenic precursor cells were normally distributed in the presence of both transgenes.
The R26R reporter mouse is a strain that has been engineered to allow the early detection of Cre recombinase activity in tissues through lacZ conditional expression (Soriano, 1999) . Crossing the Col2a1-Cre transgene in the R26R background therefore allowed the detection of the Col2a1-expressing chondrogenic precursors. We further brought together the three transgenes (bS-Hoxa2-lacZ, Col2a1-Cre, and R26R) in the same pups and compared the distribution of precursor cells with that observed in controls (Col2a1-Cre/R26R). Patterning defects or massive cell death arising upon Hoxa2 induction should display an altered abundance or distribution of Col2a1-Cre-expressing cells in the presence of the bS-Hoxa2-lacZ transgene. Embryos were harvested at E10.5, when progenitor cells migrate from the somites and condense. At this stage, these cells express Col2a1-Cre, as reported by Ovchinnikov et al. (2000) . No obvious difference in stained cells' distribution was found between Col2a1/Hoxa2-lacZ (n 5 3) and Col2a1-Cre (n 5 3) transgenic embryos in the R26R background (Figs. 4A,4B ), indicating that cells were equally abundant and similarly patterned in the presence or absence of the Hoxa2-inducible transgene. To exclude the possibility that the similar precursor cell distribution in these embryos reflects a low penetrance of the skeletal phenotype in the R26R genetic background, we looked at the skeletons of E18 fetuses in the progeny of identical crosses. Col2a1/ Hoxa2-lacZ double transgenics in the R26R background (n 5 7) showed exactly the same malformations at the same frequency as those reported in Table 2 . These data therefore demonstrate that the phenotype resulting from the Col2a1-Cre-mediated induction of Hoxa2 is not due to late patterning defects or massive cell death. Overall cartilage maturation defects upon persistent Hoxa2 expression
To unravel the cause of the observed skeletal defects, each maturation step of skeletogenesis was addressed in Col2a1/Hoxa2-lacZ mutants. Histological and immuno-histochemical examination was carried out on Col2a1/Hoxa2-lacZ and bS-Hoxa2-lacZ or WT E15.5 fetuses. At this developmental stage, proliferative, hypertrophic, mineralized, and ossified cartilages are visible in normal pups. In WT (n 5 5) and bS-Hoxa2-lacZ fetuses (n 5 4), bones and cartilage appeared well developed. In contrast, Col2a1/Hoxa2-lacZ mutants (n 5 7) showed chaotic cartilages organization with smaller differentiated hypertrophic areas (Figs.  4C,4D ). Their vertebral column looked about half the normal size and spinous processes were hypoplastic or even absent. At E15.5, chondrocyte proliferation was examined through PCNA immunostaining. In both bSHoxa2-lacZ (n 5 3) and Col2a1/Hoxa2-lacZ (n 5 3) spines, proliferating cells were localized at the vertebral bodies periphery with a higher density around intervertebral disks (Figs. 4E,4F) . No difference in proliferating cells number or localization was seen between simple-and double-mutant mice (Fig. 4G) . The maturation of the hypertrophic cartilage was assessed by type-X collagen immunostaining. While an expected strong signal was precisely detected in the vertebral bodies centrum of WT (n 5 2) and bS-Hoxa2-lacZ (n 5 3) pups, it appeared milder and dispersed in double transgenics (n 5 3; Figs. 4H,4I). Finally, cartilage mineralization, emphasized by Von Kossa's/AR staining, was clearly delayed in double transgenics (n 5 3) as compared with control pups (n 5 3). It was even practically absent in the basihyoid (Figs. 4J,4K ). All these observations were also noticed for double-mutant limbs and ribs, although they were less pronounced.
In conclusion, while the proliferation of chondrocytes did not appear to be affected by a persistent Hoxa2 expression, the whole cartilaginous maturation process appeared impaired in Col2a1/Hoxa2-lacZ mice. In addition, Hoxa2 misregulation equally affected skeletal derivatives of either NC or mesoderm origin.
Hoxa2 expression in chondrogenic precursors impairs the initial differentiation steps
Whether the above-mentioned maturation defects could be related to an initial differentiation failure in Col2a1/ Hoxa2-lacZ mice remained to be addressed. To investigate on this issue, whole-mount double-mutant skeletons were examined at E13.5. At this stage, chondrocyte differentiation has progressed and hypertrophy has just begun in normal mice. Surviving Col2a1/Hoxa2-lacZ mice were thus mated together and embryos were collected. One resulting litter was genotyped and processed for alcian blue staining. Consistent with a mendelian distribution, 6/13 embryos were negative for at least one of the transgenes (bSHoxa2-lacZ or Col2a1-Cre). Those embryos presented a normal skeletal development, particularly in the verteb- ral column, ribs, basihyoid, otic capsule, and Meckel's cartilage (Figs. 5A,5C,5E). Conversely, the most affected double mutants (2/13) displayed almost no axial skeleton but rudiments of basioccipital, exoccipital, atlas, and distal ribs (Figs. 5B,5D ). The Meckel's cartilage was occasionally split in its proximal part ( Fig.  5F ) and sometimes, the basihyoid was not yet differentiated. The remaining progeny (5/13) showed an intermediate phenotype.
When looking at the X-gal staining intensity in E13.5 litters, the embryos showing the highest staining also displayed the most affected structures (data not shown). This correlation is suggestive of a gene dosage effect on the expressivity of the phenotype, which would explain the occurrence of a low number of more severely affected embryos interpreted as homozygous for the induced bS-Hoxa2-lacZ transgene. This could also explain the apparent co-localization of Meckel's cartilage splitting point with an intense X-gal staining spot (compare Figs. 2B,5F ). In contrast, staining was never detected in some rostral-affected structures like the presphenoid or the nasal capsule, which might display a higher sensitivity to Hoxa2 misexpression.
To further delineate the impact of the sustained Hoxa2 expression on the chondrogenic cascade, we looked at the expression of two of the earliest chondrogenic determinants, FGF receptor 3 (Fgfr3) and Sox9. Fgfr3 and Sox9 are both expressed at the very onset of differentiation and their expression persists up to the prehypertrophic stage. As Fgfr3 indirectly stimulates the expression of Sox9 (Murakami et al., 2000) , an alteration in their relative expression domains would mean that Hoxa2 interferes at some point within this cascade in Col2a1/Hoxa2-lacZ mice. As expected, Hoxa2 was only detected in the vertebral column of Col2a1/Hoxa2-lacZ mutants. This staining was prominently found in undifferentiated cells lying at the periphery of restricted developing cartilages (Figs.  6A-6C ). In both WT (n 5 2) and bS-Hoxa2-lacZ (n 5 2) E13.5 embryos, strong immunostaining signals for Sox9 and Fgfr3 were observed in differentiating vertebral bodies (Figs. 6D,6F ). Strikingly, upon Hoxa2 induc- tion, detection of both Fgfr3 and Sox9 was equally limited to those restricted cartilaginous areas (n 5 2; Figs. 6E,6G), thereby suggesting that the downregulatory effect of Hoxa2 on cartilage differentiation takes place upstream of both these chondrogenic players.
Altogether, our results indicate that persistent Hoxa2 expression in precartilaginous primordia impairs the very initial chondrogenic differentiation process and that chondrogenic precursors, whatever their NC, paraxial, or lateral mesoderm origin, are equally affected. This global impairment of differentiation would not result from a direct inhibition of Sox9 expression but rather grounds upstream of the stimulatory FGF signaling occurring at the onset of the chondrogenic program.
The Hoxa2-induced impairment of chondrogenesis does not affect further ossification As already mentioned, the surviving double transgenics appear smaller than the unaffected simple transgenic or WT littermates. This difference was progressively marked after birth and appeared the most apparent by postnatal day 5 (vertex-sacrum size: double mutants to control ratio of 0.78 AE 0.07; n 5 4). The overall size difference between double transgenics and control animals could be correlated to size differences in equivalent vertebrae. The height of nine vertebrae (C2-C4, T5-T7, and L3-L5) of double transgenics was measured 1 day after birth and on the day of their death (postnatal days 5, 28, 51, and 56) and compared with those of control littermates at the same age. The relative vertebral size was decreased in Hoxa2 expressers as compared with controls (axial size ratio of 0.63 AE 0.26; n 5 12). This postnatal growth defect caused by the expression of Hoxa2 in chondrocytes is consistent with the differentiation defect observed at fetal stages.
To address whether the impaired chondrogenesis was followed by a deficit in ossification per se or not, BMD was determined by pQCT in the C3, T6, and L4 vertebrae of those individuals for which the vertebral sizes were compared. BMD of Col2a1/Hoxa2-lacZ mutants did not appear significantly different from control littermates (383.1 AE 154.0 mg/cm 3 in double mutants versus 312.9 AE 104.6 mg/cm 3 in controls, n 5 12), providing evidence that the Hoxa2-mediated chondrodysplasia did not affect the subsequent ossification process as such.
Discussion
In the mouse, cartilages start to develop from mesenchymal condensations, while the expression of patterning Hox genes expression turns off. This temporal sequence of events underlies an unresolved functional link between the fading down of Hox expression and the onset of chondrocyte differentiation. In this study, we generated transgenic mice that allow conditional Cremediated ectopic and heterochronic expression of Hoxa2. These mouse lines were used to investigate why such a Hox gene needs to be down-regulated to engage chondrogenic differentiation programs. To this end, we induced Hoxa2 activity beyond the onset of chondrocyte differentiation and analyzed the impact of a sustained expression of Hoxa2 on cartilage development. We therefore demonstrated that Hoxa2 activity has a drastic down-regulatory effect on chondrocyte differentiation, which results in chondrodysplasia of NC, sclerotome, and lateral mesoderm-derived skeletal elements.
Col2a1/Hoxa2-lacZ double transgenic mice show reduced or malformed secondary palate, nasal capsule, neurocranium, viscerocranium, otic capsule, vertebral column, ribs, and limbs. The lacZ staining of precursor cells expressing Col2a1 revealed that their distribution was unaffected in the double mutants. Immunostaining of proliferating cells at E15.5 further showed that chondrocytic proliferation was also unaffected. However, alcian blue staining of early developing cartilage supported that the chondrodysplasic phenotype can be interpreted as resulting from an initial differentiation failure. At E13.5, while WT embryos display a wide cartilaginous skeleton, the most affected double mutants lack axial skeleton structures but only show occipital, cervical, distal ribs, or otic capsule rudiments. As a possible consequence, at E15.5, the skeleton of the affected individuals presents a severe maturation delay during the hypertrophy, mineralization, and ossification steps. Finally, ectopic Hoxa2 expression during chondrogenesis led to perinatal or early lethality for more than one-third of the double transgenic individuals. This variation in survival does not seem to reflect differences in the level of the Hoxa2 expression upon Cre-mediated recombination. Indeed, the semi-quantitative estimate of Hoxa2 expression in double transgenic E13.5 embryos did not reveal gross variation in Hoxa2 expression level. Rather, the susceptibility to early lethality may be due to the relative genetic heterogeneity of the offsprings of crossings between Col2a1-Cre and bS-Hoxa2-lacZ lines. In fact, these transgenes have been maintained in distinct, C57BL/ 6xSJL hybrid (Ovchinnikov et al., 2000) and FVB inbred genetic backgrounds, respectively.
Previously reported ectopic and sustained expression of Hoxa2 led to distinct phenotypes according to the cell populations that were targeted for Hoxa2 misexpression and to the experimental design leading to different timing and persistence of Hoxa2 expression. Some ectopic activation of Hoxa2 resulted in patterning modifications but did not give rise to differentiation defects as such (Grammatopoulos et al., 2000; Pasqualetti et al., 2000) . Other misexpression experiments did not lead to homeotic transformations (Grammatopoulos et al., 2000; Creuzet et al., 2002) , but rather to a deficit in skeletal development. As previously discussed (Grammatopoulos et al., 2000; Pasqualetti et al., 2000; Creuzet et al., 2002) , the different outcomes of Hoxa2 misexpression might reflect that in some instances, both NC cells and branchial arch host tissue were targeted while in others, Hoxa2 was only misexpressed in the NC. However, critical differences between these experiments also reside in that Hoxa2 misexpression was either transient or sustained.
Although our data parallel those obtained when only the NC cells were targeted to express Hoxa2 ectopically (Grammatopoulos et al., 2000; Creuzet et al., 2002) , these experiments should be compared cautiously. In the work presented here, the timing of Hoxa2 misexpression and the cellular population that ectopically expressed this gene were clearly different from the previously reported experiments. In fact, by inducing Hoxa2 expression in Col2a1-expressing cells, NC and branchial arches are allowed to be normally patterned. Hoxa2 was thus precisely misexpressed only in cells that are normally committed to enter chondrogenesis and only at the precise stage chondrocyte differentiation goes on. This implies that not only the skeletogenic NC but also other skeletogenic compartments, i.e., paraxial and lateral plate mesoderm, were targeted and consistently showed chondrodysplasia. Altogether, our results therefore show that on a cell-autonomous basis, Hoxa2 persistent expression delays chondrocyte differentiation, by acting just upstream of a common basic chondrogenic program. As the selective down-regulation of the chondrogenic cascade occurs after migration of the precursors, Hoxa2 is proposed to fulfill distinct but yet related roles during skeletal development. It could not only prevent the expression of some BA1-specific patterning genes, like Lhx6 or Ptx1, in BA2 structures (Bobola et al., 2003) but also impede premature chondrogenesis of these structures.
While patterning defects were observed in the Hoxa2 loss of function, no precocious skeletal differentiation or maturation was reported. This suggests that, in the absence of Hoxa2, early differentiation or maturation of incorrectly patterned structures or normal skeletal elements is kept under control of redundant modulators of chondrogenesis. In this regard, inactivation of the Pbx1 gene coding for a key cofactor of Hox proteins resulted in premature cartilage maturation and ossification (Selleri et al., 2001) . This indicates that the activity of other down-regulators of chondrocyte differentiation, like that of Hoxa2, relies on a partnership with Pbx1. Finally, AP-2 factors are required to provide Hoxa2 expression in the skeletogenic NC (Maconochie et al., 1999) . Interestingly, AP-2a was recently shown to inhibit chondrogenesis in ATDC5 cells (Huang et al., 2004) , which probably involves Hoxa2 as a target to mediate this anti-skeletogenic effect in vivo.
Extension of the Sox9 expression domains into Hoxa2 À / À skeletogenic territories has been reported and the forced expression of Sox9 under the control of the Hoxa2 promoter partially phenocopied the Hoxa2 KO (Kanzler et al., 1998) . Sox9 was thus proposed to be negatively regulated by Hoxa2. Consistently, similar chondrodysplasia with split Meckel's cartilage was found in Sox9 haploinsufficient mice (Bi et al., 2001) and complete inactivation of a floxed Sox9 allele in the limbs from the onset of differentiation blocked the chondrogenic cascade (Akiyama et al., 2002) . Here, we show that in Col2a1/Hoxa2-lacZ mutant skeletons, Sox9 and Fgfr3 expression domains are reduced. As Fgfr3 has been shown to stimulate Sox9 expression (Murakami et al., 2000) , Hoxa2 could affect chondrogenesis by modulating the expression of Fgfr3. In addition, preliminary real-time PCR data (unpublished results) indicate higher Sox9 expression rates at birth in Col2a1/Hoxa2-lacZ cartilages as compared with bSHoxa2-lacZ. This might reflect the observed delay in chondrocyte differentiation and cartilage maturation, as Sox9 expression has been shown to decrease during the maturation process (Ng et al., 1997) . Altogether, these data argue against a direct inhibition of Sox9 expression by Hoxa2 but rather, as was previously suggested for patterning events (Abzhanov et al., 2003; Bobola et al., 2003) , for a negative interference of Hoxa2 on the BMP and FGF pro-chondrogenic signaling cascades (Iimura et al., 1994; Murtaugh et al., 1999; Carlberg et al., 2000; Murakami et al., 2000; Zeng et al., 2002) . This interference could thus impair chondrogenesis and delay cartilaginous maturation, eventually leading to a prolonged Sox9 expression. Bapx1 (Nkx3.2) is an important modulator of the BMP signaling cascade. Bapx1 À / À mice (Triboli and Lufkin, 1999) resemble Col2a1/Hoxa2-lacZ mutants: they lack correctly shaped vertebral bodies, bony basihyoid, and supraoccipital due to chondrogenesis failure and they display altered Fgfr3 and Bmp4 expression patterns. In addition, Bapx1 was shown to induce Sox9 expression by mediating the Shh-dependent response of the prechondrogenic mesoderm to BMP signals (Zeng et al., 2002) . Moreover, the Xenopus Bapx1 homolog is down-regulated in BA1 following a targeted XHoxa2 gain of function (Pasqualetti et al., 2000) , suggesting that decreased Bapx1 activity may also be involved in the Hoxa2-mediated impairment of chondrogenesis.
Another important finding is that not only endochondral structures but also some membranous bones were affected in Col2a1/Hoxa2-lacZ transgenics. The pterygoid and tympanic ring as well as the whole face were reduced, contrary to what occurs in Col2a1 KO mice in which only cartilaginous matrix deposition is affected (Li et al., 1995) . This could result from perturbed interactions between growing membranous bones and the adjacent cartilages or from a direct inhibition of membranous ossification following transgene activation into the dermis as suggested by a previous study (Kanzler et al., 1998) . The unexpected Col2a1-Cre expression in the dermis that presumably results in the crumpled skin of double transgenics newborns is supposed to arise from the ectopic activity of the Col2a1 promoter fragment contained in the Col2a1-Cre transgene. Ectopic activity of integrated transgenes is a commonly observed phenomenon. It is worth noticing that another Col2a1-Cre transgenic line has been generated by Sakai et al. (2001) for which nonchondrocytic Cre expression was also reported.
Is the anti-skeletogenic activity specific of Hoxa2 or is it a common property of the entire Hox family? Overexpression of Hoxd4 and Hoxc8 in their own expression domains resulted in a closely similar chondrodysplasia due to an accumulation of proliferating chondrocytes with no further hypertrophic differentiation (Yueh et al., 1998) . Hoxc8 was further shown to mediate the BMP-induced osteoblastic differentiation through cooperation with Smad1, an early effector of BMPs, and to participate to the Smad6-dependent negative feed-back loop on BMP signaling (Bai et al., 2000) . This has to be paralleled with the observation that mice lacking Pbx1 exhibit premature differentiation and maturation of cartilages, while no Hox loss of function displayed such a phenotype. This points toward a possible redundancy in the shared ability of Hox proteins to restrain early chondrogenic differentiation.
In conclusion, forcing the expression of Hoxa2 to persist at a stage of chondrogenesis in which it should be normally switched off led to severe chondrodysplasia in transgenic mice. By inducing the conditional expression of Hoxa2 at the onset of chondrocyte differentiation, we demonstrated that, independently of its role in patterning and shaping bones, this gene, presumably like other Hox genes, keeps chondrogenic differentiation under control from its beginning. We therefore propose that Hoxa2 expression is required up to a stage precursor cells assemble in condensations and have to remain undifferentiated, while later on, differentiation and maturation of cartilage occurring, Hoxa2 needs to be silenced.
